Zuckerberg initiative poaches AstraZeneca board member
Mark Zuckerberg announces the Chan Zuckerberg Initiative to "cure, prevent or manage all disease" by the end of the century during a news conference at UCSF Mission Bay in San Francisco, California, U.S. September 21, 2016. REUTERS/Beck Diefenbach
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
LONDON (Reuters) - The $3 billion health initiative set up by Facebook co-founder Mark Zuckerberg and his wife Priscilla Chan has hired one of AstraZeneca's non-executive directors to head up its science drive.
The British drugmaker said on Wednesday that Cornelia Bargmann would step down from its board next month to take up a new role as president of Chan Zuckerberg Science, part of the Chan Zuckerberg Initiative.
Leif Johansson, AstraZeneca's chairman, said the board was sorry to see her leave but understood Bargmann's decision to focus on the new assignment.
Zuckerberg and Chan unveiled their new initiative last week, with a goal to "cure, prevent or manage all disease within our children's lifetime".
Their plan echoes the big global health ambitions of the Bill & Melinda Gates Foundation, another philanthropic endeavor funded by tech industry money that has similarly tapped the pharmaceuticals sector in the past for key staff.
On the plus side, AstraZeneca also said it had hired Columbia University genetics expert David Goldstein to the consultative role chief adviser for genomics. Goldstein, who will continue his academic jobs, had previously served as chair of AstraZeneca's genomics advisory panel.
The company unveiled a 10-year plan in April for a massive gene hunt in the biggest bet yet by a drugmaker on the potential of genetic variations to unlock routes to new medicines.
(Reporting by Ben Hirschler; Editing by Adrian Croft)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Column: How part-time work hurts U.S. workers' retirement security
- Despite Brexit, EU makes progress on capital market plan
Create E-mail Alert Related CategoriesReuters
Related EntitiesMark Zuckerberg
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!